Caval Approach Impacts Tumor Recurrence Risk After Transplant
Compared with caval sparing, total caval replacement for recipient hepatectomy in liver transplant may protect against post-transplant tumor recurrence.
Read More
Liver Disease
Liver Transplant Impacts eGFR in Patients With MASH
Liver transplant impacts post-transplant renal function, specifically eGFR, in patients with metabolic dysfunction-associated steatohepatitis.
Read More
Surgical Refinements Reduce Biliary Complications
Refinement in microsurgical biliary reconstruction techniques has led to a decrease in early biliary complications after living donor liver transplant.
Read More
Statin Use Beneficial for Patients With MASH-Related Cirrhosis
Statin therapy has a beneficial effect in patients with MASH and decompensated cirrhosis being evaluated for liver transplant.
Read More
Non-Medical Barriers to LDLT Persist at Multiple Levels
Non-medical barriers to living donor liver transplants persist at recipient, donor, and professional levels and impact wider adoption of the procedure.
Read More
Composite Biomarker Could Reduce Need for Biopsies
A composite biomarker approach that uses multiparametric MRI and serum liver tests could enhance monitoring of liver grafts.
Read More
Q&A: Challenges in Living Donor Transplant for Alcohol-Associated Hepatitis
Emerging data on living donor liver transplant for alcohol-associated hepatitis shows the procedure offers a survival benefit over medical management alone.
Read More
Cirrhotic Cardiomyopathy May Increase MACE in Liver Transplant
For patients undergoing liver transplant, the presence of cirrhotic cardiomyopathy was related to a trend toward increased major adverse cardiac events.
Read More
Abdominal Aortic Calcification Tied to Coronary Artery Calcium
Abdominal aortic calcification was linked to coronary artery calcium score among patients undergoing liver transplant.
Read More
Using MRE to Predict Cirrhosis and Decompensation in ALD
A recent study found that MRE-based liver stiffness measurements predicted cirrhosis and decompensation in patients with early-stage ALD.
Read More
High F-CAL Values May Support Prognosis in Advanced Chronic Liver Disease
Fecal calprotectin was independently proportional to the risk for adverse outcomes, defined as death or liver transplant, in advanced chronic liver disease.
Read More
Frailty Impacts Mortality Risk in Patients on Transplant Waitlist
Improvements in the Liver Frailty Index resulted in declines in mortality risk among patients on the liver transplant waitlist.
Read More
ABO-Incompatible Transplants Comparable to ABO-Compatible Ones
ABO-incompatible living donor liver transplantation provides outcomes comparable with ABO-compatible liver donors.
Read More